Upload
cornejo1
View
225
Download
0
Embed Size (px)
Citation preview
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
1/23
Differential Diagnosis of AnxietyDisorders
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
2/23
Objectives
Define anxiety and be able to identify
when it goes from being normal to being
pathological
Become familiar with the major anxiety
diagnoses, including diagnostic criteria,
prevalence, onset, typical course and
treatment
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
3/23
Define Anxiety
Miriam-Webster Medical Dictionary
1. a: a painful or apprehensive uneasiness of mindusually over an impending or anticipated ill b: a causeof anxiety = NONPATHOLOGICAL
2. an abnormal and overwhelming sense ofapprehension and fear often marked by physiologicalsigns (as sweating, tension, and increased pulse), bydoubt concerning the reality and nature of the threat,and by self-doubt about one's capacity to cope with it= PATHOLOGICAL
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
4/23
Anxiety Definition
Features of Pathological Anxiety Autonomy: no or minimal recognizable
environmental trigger
Intensity:exceeds the patients capacity tobear discomfort
Duration: the symptoms are persistent ratherthan transient
Behavior: anxiety impairs coping andresulting in disabling behavioral strategiessuch as avoidance or withdrawal
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
5/23
Anxiety Definition
Manifestations of Anxiety Physical symptoms: related to autonomic
arousal (elevated pulse or resp rate, physical
tension, nausea, sweating) Affective Symptoms: ranging from mild
edginess to severe terror
Behavior: avoidance or compulsions
Cognitions: worry, apprehension,obsessions, and thoughts about emotional orbodily damage
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
6/23
Workup
Dont forget medical workup! Especially if historynot typical, if family history negative, in absenceof stressors, in older patient, or unusual physicalsx/signs
Possible medical causes: Hyperthyroidism
Carcinoid
Hyperparathyroidism Pheochromocytoma
Hypoglycemia
Substance intoxication or withdrawal
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
7/23
DSM-IV-TR Anxiety Disorders
Panic Disorder (with or withoutAgoraphobia)
Generalized Anxiety Disorder
Obsessive Compulsive Disorder
Post Traumatic Stress Disorder
Acute Stress Disorder
Social Phobia
Specific Phobia
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
8/23
Panic Attack
Associated with many different anxiety disorders(Panic D/O, GAD, Phobias, etc and can be seen inMDD as well)
Discrete period of intense fear or discomfort, with 4(or more) symptoms onset suddenly and reach apeak in 10 minutes
SYMPTOMS:
Palpitations
Sweating
Shaking
Shortness of breath Choking
Chest pain Nausea
Dizziness/Feeling Faint Derealization or depersonalization
Fear of losing control or going
crazy Fear of dying
Paresthesisas
Chills or hot flushes
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
9/23
Panic Disorder
Criteria:
Recurrent Unexplained Panic Attacks
After at least one attack, 1+ month of at
least one symptom:
1. Worry about more attacks2. Worry about what the attack means or
what will happen after (e.g.. Having an
MI, going crazy)
3. A significant change of behavior related
to attacks Not due to substances/medical
condition, or a different anxiety disorder
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
10/23
Panic Disorder and Agoraphobia
Agoraphobia literally means fearof the marketplace
DSM Criteria:1. Anxiety about being in places from which
escape might be difficult or embarrassing ifthey felt panicky
2. These situations are then avoided orendured with marked distress (or only witha companion)
3. Not better accounted for by another
anxiety disorder (e.g. specific phobia formalls or social phobia)
Agoraphobia is highly overlappingwith Panic D/O
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
11/23
Panic Disorder
Lifetime prevalence Panic 3.5%, Agoraphobia 5.3%
Prevalence per Year Panic 2.3%, Agoraphobia 2.8%
2:1 female: male ratio Typically onset in 20s (79% before age 30)
Usually wax and wane over time80% havereoccurence, but 70 % have remissions
50% will also have depression, 20% will have alcohol
abuse Treatment Medication (SSRIs, MAOIs, short term
benzos, beta-blockers) and Therapy (CBT, behavioralcomponent needed for agoraphobia)
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
12/23
Generalized Anxiety Disorder
Criteria: Excessive anxiety and worry, more days
than not, for 6+ months, about morethan one topic
Cannot control the worry
With 3 or more of the followingsymptoms (1 in kids): Restlessness
Easily fatigued
Difficulty concentrating
Irritability
Muscle tension Sleep Disturbance
Not due to another anxiety d/o
Not due to another anxiety disorder,substances or medical condition
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
13/23
Generalized Anxiety Disorder
Lifetime Prevalence 5.1%, 1 year Prevalence 3.1%
2:1 female: male ratio
Typical onset in adolescent-20s, although can occur atany time
Course is prolonged with fluctuations in symptoms andup to 25% may develop panic at follow-up
Overall felt to be milder disorder than panic ordepression, with only 10% of anxious patients seen by
psychiatrists diagnosed with GAD Treatment: Primarily therapy (CBT, behavioral) but meds
(benzos, beta blockers) when symptoms particularly bad,+/- SSRI, Buspar if chronically symptomatic
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
14/23
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
15/23
Obsessive-Compulsive Disorder
Prevalence of 2-3% in General population
Onset typically teens to early 20s (only 5% onset afterage 35)
Common obsessions: aggression, contamination,
symmetry, sexual, hoarding, religious, somatic Key differential diagnosis feature: obsessions are ego-
dystonic but recognized as their own thoughts
Roughly equal male to female, although may have slightfemale predominance, but 75% of childhood onset in
males Typically chronic course and difficult to treat
Treatment: Medications (high dose SSRIs,clomipramine) and therapy (exposure with responseprevention)
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
16/23
Post Traumatic Stress Disorder Criteria:
1. Person experienced a traumaticevent with actual or threateneddeath, injury, or threat to personalintegrity, about which they felt fearand helplessness
2. Persistently re-experienced through(1 or more) Intrusive recollections
Recurrent dreams of event
Flashbacks (feeling as if reliving
experience) Intense distress at exposure to cues of
event
Physiological reactivity to cues of event
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
17/23
Post Traumatic Stress Disorder3. Avoidance of Stimuli associated with event (3 or more)
Efforts to avoid thoughts, feelings or conversations about the event Efforts to avoid activities, places or people that provoke memories of
event
Inability to recall important aspects of the event
Diminished interest or participation in usual activities
Feeling estranged from others
Restricted range of affect Sense of foreshortened future
4. Symptoms of increased arousal (2 or more) Difficulty falling or staying asleep
Irritability or anger outbursts
Difficulty concentrating
Hypervigilance Exaggerated startle response
5. Symptoms occur for more than one month (if for less than 1 month,consider Acute Stress Disorder)
6. Causes significant distress or functional impairment
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
18/23
Post Traumatic Stress Disorder
Prevalence: 0.5% in men, 1.2% in women,lifetime prevalence up to 8%
Can occur at any age (kid burn pts up to 80%PTSD at 1 year, only 30% in adults)
Traumatic events: For men, most due to combat.For women, most likely physical assault or rape.
Treatment: Medications (antidepressants,buspar, mood stabilizers, betablockers, benzos,
antipsychotics) and therapy (individual, CBT,group)
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
19/23
Social Phobia
Criteria: Persistent fear of one or more social or
performance situations where he/she willbe around unfamiliar people, where he orshe fears acting in a way to that will behumiliating or embarrassing
Exposure to feared situation causesanxiety (possibly a panic attack)
He/she recognizes fear is excessive orunreasonable
The feared situation is avoided and this
avoidance/anxiety has functionallimitations
Duration > 6mo (in adults)
Not due to other anxiety d/o, medicalillness, or substances
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
20/23
Social Phobia
Prevalence between 3-13%
Female > male in community samples, male >female in clinical samples
May be limited (performance anxiety) orgeneralized
Onset either in late adolescence or in earlychildhood
Tends to develop slowly but is chronic but
fluctuating Treatment: Medications (SSRIs, MAOIs, benzos,
beta blockers) and therapy (CBT, behavioral)
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
21/23
Specific Phobias
Criteria: Persistent fear that is excessive or
unreasonable caused by the
presence of anticipation of a specific
object or situation
Exposure to the feared thingprovokes anxiety (possibly PA)
The phobic situation is avoided or
endured with intense distress
The avoidance, anticipations or
distress cause functional impairment Duration > 6 months in adults
Not due to other anxiety d/o, medical
illness, or substances
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
22/23
Specific Phobias
Types of Phobias
Animal type (snakes, spiders)
Natural Environment type (heights, storms)
Blood-injection-injury type (highly family
associated and strong vasovagal response)
Situational Type (flying, driving, elevators)
Other type (vomiting, choking, hypochondria,clowns)
7/30/2019 Psychres Differential Diagnosis of Anxiety Disorders
23/23
Specific Phobias
Lifetime prevalence 10-25%
Onset most often in childhood (especiallyanimals, natural, blood-injection-injury types).Situational phobias have a bimodal distribution:
1 peak in childhood and 1 in mid 20s. May spontaneously remit, few come to
psychiatric attention (on 2-3% of psych pts)
Treatment: Exposure based interventions
(systematic desensitization, flooding andparticipant modeling), may also need meds(SSRI, MAOI, benzos)